Leelyn Smith’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.27M | Buy |
49,048
+1,781
| +4% | +$82.4K | 0.37% | 76 |
|
|
2025
Q1 | $2.88M | Sell |
47,267
-432
| -0.9% | -$26.3K | 0.51% | 53 |
|
|
2024
Q4 | $2.7M | Buy |
47,699
+215
| +0.5% | +$12.2K | 0.48% | 52 |
|
|
2024
Q3 | $2.46M | Buy |
47,484
+3,977
| +9% | +$206K | 0.44% | 67 |
|
|
2024
Q2 | $1.81M | Buy |
43,507
+4,982
| +13% | +$207K | 0.35% | 77 |
|
|
2024
Q1 | $2.09M | Buy |
38,525
+1,681
| +5% | +$91.2K | 0.42% | 68 |
|
|
2023
Q4 | $1.89M | Buy |
36,844
+605
| +2% | +$31K | 0.41% | 65 |
|
|
2023
Q3 | $2.1M | Buy |
36,239
+651
| +2% | +$37.8K | 0.51% | 56 |
|
|
2023
Q2 | $2.28M | Sell |
35,588
-1,447
| -4% | -$92.5K | 0.55% | 54 |
|
|
2023
Q1 | $2.57M | Buy |
37,035
+553
| +2% | +$38.3K | 0.66% | 46 |
|
|
2022
Q4 | $2.62M | Buy |
36,482
+2,142
| +6% | +$154K | 0.72% | 43 |
|
|
2022
Q3 | $2.44M | Hold |
34,340
| – | – | 0.84% | 29 |
|
|
2022
Q2 | $2.64M | Buy |
34,340
+1,117
| +3% | +$86K | 0.69% | 40 |
|
|
2022
Q1 | $2.43M | Buy |
33,223
+973
| +3% | +$71.1K | 0.63% | 44 |
|
|
2021
Q4 | $2.01M | Sell |
32,250
-425
| -1% | -$26.5K | 0.54% | 53 |
|
|
2021
Q3 | $1.93M | Buy |
32,675
+8
| +0% | +$473 | 0.56% | 51 |
|
|
2021
Q2 | $2.18M | Buy |
32,667
+510
| +2% | +$34.1K | 0.64% | 45 |
|
|
2021
Q1 | $2.03M | Buy |
32,157
+878
| +3% | +$55.4K | 0.6% | 48 |
|
|
2020
Q4 | $1.94M | Sell |
31,279
-449
| -1% | -$27.8K | 0.62% | 44 |
|
|
2020
Q3 | $1.91M | Buy |
31,728
+30,808
| +3,349% | +$1.86M | 0.68% | 35 |
|
|
2020
Q2 | $1.9M | Sell |
920
-32,218
| -97% | -$66.6M | 0.78% | 29 |
|
|
2020
Q1 | $1.85M | Buy |
33,138
+2,151
| +7% | +$120K | 0.99% | 21 |
|
|
2019
Q4 | $1.99K | Buy |
+30,987
| New | +$1.99K | 0.96% | 18 |
|